Stemline Therapeutics, Inc. Stock
Equities
US85858C1071
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
David Gionco
DFI | Director of Finance/CFO | 63 | 14-01-15 |
Jeffrey Levitt
CMP | Compliance Officer | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |